← All companies

IKT

Inhibikase Therapeutics, Inc.

IKT Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$2.21

-0.07 -3.07%

Key statistics

from XBRL data in SEC filings

Market cap

$292M

Revenue (TTM)

$0.00

Net income (TTM)

-$51.0M

EPS (TTM)

$-0.44

P/E ratio

—

Dividend yield

—

Free cash flow

-$27.8M

Cash

$49.6M

Total assets

$173M

Gross margin

—

52-week range

$1.33 – $2.53

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Unregistered sale of equity Jul 29, 2026 8-K Regulation FD disclosure Jul 23, 2026 8-K Other events Jul 14, 2026 8-K Director or officer change; Amended charter or bylaws; Shareholder vote results Jun 29, 2026 10-Q Quarter ended 2026-03-31 May 12, 2026 8-K Results of operations (earnings release) May 12, 2026 8-K Regulation FD disclosure Apr 7, 2026 10-K Fiscal year ended 2025-12-31 Mar 26, 2026 8-K Results of operations (earnings release) Mar 26, 2026 8-K Other events Dec 19, 2025 8-K Entered a material agreement; Other events Nov 21, 2025 8-K Other events Nov 20, 2025 10-Q Quarter ended 2025-09-30 Nov 14, 2025 8-K Results of operations (earnings release) Nov 14, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Aug 14, 2025 8-K Shareholder vote results Jun 30, 2025 10-Q Quarter ended 2025-03-31 May 14, 2025 8-K Results of operations (earnings release) May 14, 2025 10-K/A Fiscal year ended 2024-12-31 Apr 25, 2025 8-K Director or officer change; Regulation FD disclosure Apr 14, 2025 10-K Fiscal year ended 2024-12-31 Mar 27, 2025 8-K Results of operations (earnings release) Mar 27, 2025 8-K Entered a material agreement; Unregistered sale of equity; Director or officer change; Regulation FD disclosure Feb 24, 2025 8-K Director or officer change; Regulation FD disclosure Feb 18, 2025 8-K Other events Jan 29, 2025 8-K Amended charter or bylaws; Shareholder vote results Jan 6, 2025 8-K Terminated a material agreement Dec 5, 2024 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Entered a material agreement; Director or officer change; Regulation FD disclosure Oct 22, 2024 8-K Entered a material agreement; Unregistered sale of equity; Director or officer change; Regulation FD disclosure; Other events Oct 10, 2024 8-K Regulation FD disclosure Oct 9, 2024 10-Q Quarter ended 2024-06-30 Aug 14, 2024 8-K Shareholder vote results Aug 6, 2024 8-K Shareholder vote results Jun 10, 2024 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure May 20, 2024 10-Q Quarter ended 2024-03-31 May 15, 2024 8-K Regulation FD disclosure; Other events Apr 30, 2024 8-K Regulation FD disclosure Apr 19, 2024 8-K/A Director or officer change Apr 2, 2024